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Abstract
Both actin and microtubules are major cytoskeletal elements in eukaryotic cells
that participate in many cellular processes, including cell division and motility,
vesicle and organelle movement, and the maintenance of cell shape. Inside its
host cell, the human pathogen Chlamydia trachomatis manipulates the
cytoskeleton to promote its survival and enhance its pathogenicity. In particular,
Chlamydia induces the drastic rearrangement of both actin and microtubules,
which is vital for its entry, inclusion structure and development, and host cell
exit. As significant progress in Chlamydia genetics has greatly enhanced our
understanding of how this pathogen co-opts the host cytoskeleton, we will
discuss the machinery used by Chlamydia to coordinate the reorganization of
actin and microtubules.
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Introduction
The Chlamydiaceae constitute a family of obligate intracellular
bacteria that encompasses numerous species. With ~92 million
new cases/year worldwide, Chlamydia trachomatis is the most
frequent cause of bacterial sexually transmitted infections and
is the leading cause of preventable infectious blindness called
trachoma1–3. Trachoma is a significant problem in the developing world, where access to healthcare is limited and antibiotics
are scarce. Chlamydia infections are also associated with chronic
diseases and increased risk for cervical cancer4,5, making this
infection a significant socioeconomic and medical burden in both
developed and developing countries.
Chlamydiae exhibit a unique biphasic life cycle, cycling between
a metabolically inactive but infectious small elementary body
(EB ~200 nm) and a noninfectious metabolically active and dividing large reticulate body (RB ~800 nm)6. Chlamydia spends the
majority of its life as an intracellular RB. Soon after invasion, EBs
differentiate into RBs and replicate within a membrane-bound
compartment called an “inclusion”. This obligate intracellular
lifestyle required Chlamydia to develop an effective strategy to
manipulate host cell pathways in order to ensure its survival and
replication. Among the many pathways that Chlamydia co-opts, a
common and intriguing target for all Chlamydia species has emerged:
the host cytoskeleton7. We will discuss the recent advances concerning the role played by the host cytoskeleton in the growth and
structural maintenance of the chlamydial inclusion (see Figure 1).

Chlamydia trachomatis recruits actin to enter its
host cell and uses microtubules to travel to the
microtubule-organizing center
Because of their obligate intracellular nature, Chlamydiae have
evolved very efficient ways to enter eukaryotic cells (Figure 1A).
During infection, EBs attach to the host cell surface via a relatively
weak electrostatic interaction with heparan sulfate moieties8. Then
a stronger and more specific binding to a cellular receptor takes
place, during which the majority of the EBs are internalized via
an actin-dependent event9. While a number of receptors have been
identified, including PDGFR β, β1-integrin, and Ephrin A2, depletion of a single receptor is not sufficient to block entry, suggesting
that Chlamydia utilizes more than one receptor to invade its host
cell10,11.
To promote entry into non-phagocytic epithelial cells, C. trachomatis delivers a translocated actin-recruiting phosphoprotein (Tarp,
also known as CT456)12–14 into the host cytoplasm (Figure 1A). In a
phosphorylation-dependent manner, Tarp recruits guanine nucleotide
exchange factors that activate Rac1, a member of the Rho family of
GTPases9,10,13,15. Whereas Chlamydia caviae uses both Rac1 and
Cdc42 to promote its entry, C. trachomatis recruits only Rac1, and
not Cdc42 or RhoA16,17. Hijacking only one Rho GTPase family
member is unique to C. trachomatis, as other intracellular bacteria
including Salmonella and Shigella usually use multiple isoforms
such as RhoA and Cdc4218–20. In addition to its Rac1 recruitment
function, Tarp also directly binds to actin monomers and nucleates
new unbranched actin filaments21,22. These linear filaments are then
branched via the host Arp2/3 complex, which is activated by the

Rac1 signaling pathway9,13. Thus, Tarp functions as both an actin
nucleator and a signaling platform to locally remodel the actin
cytoskeleton and promote Chlamydia invasion.
Nascent C. trachomatis-containing inclusions then use the
minus-end-directed microtubule motor dynein to move from the
cell periphery to the microtubule-organizing center (MTOC),
where the inclusion resides for the duration of the life cycle23
(Figure 1B). This is a pathogen-driven event in which the inclusion protein CT850 is involved through its interaction with
the dynein light chain DYNLT124. At the MTOC, Src family kinases control the tight association between inclusions and
centrosomes25. Additional inclusion proteins including IncB,
CT101, and CT222 are concentrated at these contact points
between inclusions and centrosomes, suggesting their potential
contribution to the transport of the inclusion24. In fact, during
Chlamydia psittaci infection, IncB has been shown to interact
with Snapin, which also binds dynein, thus connecting the inclusion to the microtubule network26. The association of inclusions
with the MTOC is a common characteristic for a number of
Chlamydia species, suggesting that this event is essential for
Chlamydia’s life cycle. One possibility is that the MTOC brings
host organelles and chlamydial inclusions in close proximity, thus
facilitating the transfer of nutrients and lipids from the host to
the inclusion. Additionally, the clustering of the inclusions at the
MTOC is necessary for the homotypic fusion of inclusions to
take place during C. trachomatis infection, as the dissociation of
the inclusions from the MTOC inhibits this fusion event27. Homotypic fusion is critical for C. trachomatis pathogenicity, as nonfusing mutants grow significantly slower than their wild-type
counterparts28,29. In particular, C. trachomatis strains that do not
undergo homotypic fusion are also replication-defective and cause
significantly milder disease in humans28–30. Given the importance
of microtubule-based transport of the inclusion in Chlamydia
development, additional unidentified Chlamydia effectors are
likely involved in this process.

Chlamydia creates microtubule cages to support the
development of its inclusion
Around 12 hours post-infection (PI), microtubules likely assemble around the inclusion under the control of the chlamydial
effector CT223/IPAM, which has been shown to alter microtubule organization through the host centrosomal protein of
170 kDa (CEP170) in transfected cells31 (Figure 1C). There, microtubules encasing the inclusion are stabilized, which allows them to
undergo post-translational modifications (PTMs), including
detyrosination and acetylation32,33 (Figure 1D). These PTMs influence microtubule structure and depolymerization rates34 and
have been implicated in the relocation of the Golgi apparatus
around the chlamydial inclusion32,33. In most cells, dynamic microtubules have a half-life of about 5–10 minutes, while modified
microtubules can persist for hours35, suggesting that Chlamydia
uses these PTM microtubules to establish a stable long-term
relationship with its host. Detyrosination is the best-characterized
modification and involves the removal of the carboxy-terminal
tyrosine from α-tubulin by tubulin carboxypeptidase, thus exposing
a glutamic acid as the new C-terminus36.
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Figure 1. Reorganization of the host cytoskeleton during Chlamydia trachomatis infection. (A) Entry during which a translocated actinrecruiting phosphoprotein (Tarp) induces actin polymerization; (B) transport of the nascent inclusion to the microtubule-organizing center
(MTOC) using CT850; (C) formation of microtubule cages around the inclusion, in which CT223 is likely involved, and microtubule-dependent
movement of lipid droplets (LDs) and multi-vesicular bodies (MVBs) towards the inclusion; (D) post-translational modifications of microtubule
cages and positioning of Golgi mini-stacks around the inclusion controlled by CT813/InaC; (E) structural scaffolds of actin, septins, and
intermediate filaments reinforce the growing inclusion membrane in a CT813-dependent manner; (F) Chlamydia exits the host cell using
CT228-dependent extrusion (left) or through cell lysis (right).

Interestingly, stable microtubules are involved in the repositioning of organelles. During infection, the Golgi is a major source
of host lipids, including sphingomyelin and cholesterol37–40.
To enhance access to these lipids, Chlamydia induces the fragmentation of the Golgi into mini-stacks, which are then recruited
around the inclusion in a microtubule-dependent manner32,41
(Figure 1D). In addition to controlling Golgi positioning,
detyrosinated microtubules are involved in other trafficking
events, including the recycling of endocytosed transferrin42

and the dispersal of lipid droplets43, which are also co-opted
by Chlamydia39,44. Lipid droplets and multi-vesicular bodies
are redirected towards the chlamydial inclusion along microtubules to provide fatty acids, which are important for Chlamydia
replication39,40,44,45 (Figure 1C). The endoplasmic reticulum (ER)
has also been associated with stable microtubules, in particular
acetylated microtubules, along which ER tubules slide46.
Chlamydia hijacks the ER and promotes the formation of
ER-inclusion contact sites, which are important for the transfer
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of lipids to the inclusion47–49. During Chlamydia infection, the
acetylated microtubules that surround the inclusion could enable
the ER to slide towards the inclusion, thus allowing IncD/CERT
to interact with the ER-resident proteins VAPA/VAPB and form
ER-inclusion contact sites47,48. Although treatment with nocodazole, which disrupts microtubules, failed to prevent ER accumulation around the inclusion49, acetylated microtubules are
notoriously resistant to nocodazole treatment and may still be
present following treatment.
Recently, we have shown that the chlamydial protein CT813 (also
called InaC50) is critical for promoting microtubule modifications during infection through its interaction with and activation
of the small host GTPases ARF1 and ARF433, supporting prior
data showing interactions between CT813 and ARF proteins50
(Figure 1D). It is unclear how the CT813:ARF complex is
able to influence microtubule PTMs. However, inhibitors of
RhoA and ROCK (Rho-associated protein kinase) decrease the
number of inclusions associated with stable microtubules, suggesting that both of these proteins are involved in this process32.
There is evidence demonstrating that RhoA triggers microtubule
stabilization via its interaction with the mammalian homolog of
Diaphanous (mDia). The activation of mDia generates capped
microtubules, thus preventing catastrophic microtubule
disassembly51,52. Interestingly, DIAPH2 was identified in an
RNAi screen in Drosophila S1 cells as important for chlamydial
inclusion development10. It would be interesting to determine
whether C. trachomatis co-opts mDia to stabilize microtubules
and generate the post-translationally modified microtubule cages
around the inclusion, particularly since mDia is also involved
in actin polymerization53.

Chlamydia trachomatis builds actin scaffolds around
its inclusion to promote inclusion stability
As the inclusion continues to grow, actin and intermediate filaments associate with the inclusion54 (Figure 1E). This association increases progressively from ~20 hours PI until the end of
Chlamydia’s intracellular life cycle. Disruption of the actin
cytoskeleton results in the rupture of the inclusion membrane and
the leakage of C. trachomatis into the host cytoplasm, demonstrating that the maintenance of the inclusion’s integrity requires
intact actin cages54. Interestingly, RhoA—but not ROCK—also
plays a major role in this event, as it is recruited to the inclusion
and its depletion results in a substantial loss of actin scaffolds
around the inclusion54.
The chlamydial protein CT813 is the only effector identified to
date to regulate actin recruitment around the inclusion33,50
(Figure 1E). Interestingly, this function of CT813 appears to be
independent of its role in regulating post-translationally modified microtubule cages, as the overexpression of CT813 in wildtype Chlamydia results in the loss of post-translationally modified
microtubules but not actin cages33. Together, these data suggest
that both CT813 and RhoA participate in actin cage formation
and microtubule stabilization. While microtubule stabilization
also depends on ARF1/ARF4 and ROCK, actin polymerization

does not require ROCK. The role of ARF in the formation of actin
cages remains unclear, as depletion of ARF does not affect actin
polymerization33.
Recently, the actin cytoskeleton has been implicated in Golgi
reorganization during infection. Using chemical mutagenesis,
it has been suggested that CT813 organizes Golgi mini-stacks
around the inclusion through the formation of actin cages50.
However, a CT813-overexpressing Chlamydia strain that has
actin but no post-translationally modified microtubule cages
displays a defect in Golgi organization around the inclusion.
This suggests that it is the CT813-dependent induction of posttranslationally modified microtubule cages that controls Golgi
organization33. Therefore, the exact role of the actin cytoskeleton
in organelle repositioning during Chlamydia infection is still
unclear.

Chlamydia uses the actin cytoskeleton to exit host
cells by extrusion
Chlamydia exits the host cell through two mutually exclusive
mechanisms: extrusion and cell lysis (Figure 1F, left and right,
respectively). Note that to exit their host cells using the lytic
process, Chlamydia must extricate themselves from the cytoskeleton structures that encase the inclusion, in particular the
actin scaffold55. Pgp4, a transcription factor encoded by the
chlamydial plasmid, is essential for actin depolymerization prior
to cell exit, as the deletion of this regulatory gene prevents
actin disassembly and completely blocks Chlamydia exit55. The
chlamydial protease activity factor, which cleaves intermediate
filaments, is also involved in cell exit, but it does not play a role in
actin disassembly54–56.
While the lytic pathway requires actin depolymerization to
proceed, extrusion is regulated by an acto-myosin-mediated
mechanism57,58. Extrusion involves the protrusion of the intact
membrane-bound inclusion out of the cell and the pinching
off of the inclusion into a separate compartment. The resulting extruded inclusion is surrounded by the actin cytoskeleton59, the host plasma membrane, and a thin layer of cytoplasm
between plasma and inclusion membranes57. Extrusion requires
N-WASP-mediated actin polymerization and myosin II-dependent contraction of stable actin filaments57,58. The septin family of
cytoskeletal proteins regulates actin fiber formation on the inclusion membrane60 through an unknown mechanism. Interestingly,
RhoA is also involved in this process, where it specifically regulates the final stage of extrusion—pinching off and separation of the
extrusion from the host cell57.
The signals that dictate whether Chlamydia exits the host cell by
lysis or extrusion are not well understood. However, the Chlamydial inclusion protein CT228 has been shown to play a central
role in this process58. CT228 recruits the MYPTI subunit of myosin
phosphatase to microdomains on the inclusion membrane early
during infection. MYPTI-mediated phosphorylation of myosin
light chain II (MLC2) favors extrusion-mediated exit, while
the depletion or dephosphorylation of MLC2 shifts the balance
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towards the lytic pathway. Thus, Chlamydia establishes local
cytoskeletal signaling networks on the inclusion membrane to
direct its escape from the host cell.

Concluding remarks
Chlamydia has evolved efficient mechanisms to hijack essential
components of the host cytoskeleton. The successful establishment of Chlamydia’s intracellular niche and dissemination
of infectious progeny relies on the proper spatial and temporal control of both actin and microtubules. To orchestrate this
balance, Chlamydia employs effector proteins to recruit host
proteins to the inclusion membrane and modulate the activity of
host cytoskeletal signaling networks. Recent work has only begun
to shed light on the identity of these chlamydial effector proteins.
Almost a decade ago, an RNAi screen in C. trachomatisinfected Drosophila cells revealed the importance of numerous
host cytoskeleton-associated proteins in inclusion development,
supporting the critical role of the cytoskeleton during infection10.
However, limited mechanistic information regarding the role
of chlamydial effector proteins in this process was available
owing to the intractability of Chlamydia to genetic manipulation.
Recent advances in Chlamydia genetics and the expansion of the

Chlamydia genetic toolbox now provide the tools necessary to
dissect the molecular pathways and the chlamydial effectors that
control the interactions between the chlamydial inclusion and the
host cytoskeleton. Identifying these mechanisms is important not
only for understanding Chlamydia pathogenesis and developing
novel therapeutics but also because it has the potential to identify
new host cellular pathways that regulate the cytoskeleton.
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